Home›Companies›Biotech & Pharma›Abl Bio USA

Abl Bio Usa, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 7, 2023·Suggest an edit

About Abl Bio USA

Abl Bio USA is a private company based in Palo Alto, California, incorporated in 2022 in California. It has reported $2,999,900 raised in one offering on Form D since September 2023. Its chief executive is Jae Cheon Lee.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 25, 2023Sep 7, 2023$2,999,900fully sold1$2.9MEquityRule 504, Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Abl Bio USA's Form D filed Sep 7, 2023.

JL
Jae Cheon Lee
CEO and director

Sources

  1. SECABL BIO USA, Inc. filing history